TAK-448

DRUG3 trials

Sponsors

Millennium Pharmaceuticals, Inc., Takeda

Conditions

Hypogonadotropic HypogonadismLow TestosteroneProstate CancerProstatic Neoplasms

Phase 1

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

TerminatedNCT01132404

Millennium Pharmaceuticals, Inc.Prostate Cancer, Prostatic Neoplasms

Start: 2010-11-30End: 2011-12-31Updated: 2012-01-31

Phase 2

A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

TerminatedNCT02369796

TakedaHypogonadotropic Hypogonadism

Start: 2015-02-28End: 2015-11-30Updated: 2017-03-31

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

TerminatedNCT02381288

TakedaLow Testosterone

Start: 2015-09-10End: 2016-04-08Updated: 2017-05-17